Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

By Masuda Norikazu   Iwata Hiraji   Rai Yoshiaki   Anan Keisei   Takeuchi Toru   Kohno Norio   Takei Hiroyuki   Yanagita Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 443-451

Springer Publishing Company

Access to resources Recommend Favorite

A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation

By Zhou Xianxiao   Li Bailiang   Zhang Yuannv   Gu Yunyan   Chen Beibei   Shi Tongwei   Ao Lu   Li Pengfei   Li Shan   Liu Chunyang   Guo Zheng  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 505-514

Springer Publishing Company

Access to resources Recommend Favorite

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite